SEC Probe Into Biotech Co. Made Shares Drop, Investor Says
An investor in the biotechnology company Mabvax Therapeutics Holdings lodged a proposed class action in California federal court Monday, alleging the company's failure to disclose control issues and improper influence by...To view the full article, register now.
Already a subscriber? Click here to view full article